Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:15 pm Sale | 2026-03-31 | 13G | DAEDALUS SPL ACQUISITION CORP. DSAC | J. Goldman & Co LP | 1,250,000 4.870% | -237,500 (-15.97%) | Filing History |
| 2026-02-17 09:02 am Purchase | 2025-12-31 | 13G | TEXAS VENTURES ACQUISITION III TVA | J. Goldman & Co LP | 1,216,321 5.410% | 1,216,321 (New Position) | Filing History |
| 2026-02-17 09:01 am Purchase | 2025-12-31 | 13G | ANDERSEN GROUP INC ANDG | J. Goldman & Co LP | 1,160,000 9.170% | 1,160,000 (New Position) | Filing History |
| 2026-02-17 09:01 am Purchase | 2025-12-31 | 13G | DAEDALUS SPL ACQ CORP UNIT CON DSACU | J. Goldman & Co LP | 1,487,500 5.790% | 1,487,500 (New Position) | Filing History |
| 2026-02-17 09:01 am Sale | 2025-12-31 | 13G | DMY SQUARED TECHNOLOGY GROUP I DMYY | J. Goldman & Co LP | 0 0.000% | -150,000 (Position Closed) | Filing History |
| 2026-02-17 09:00 am Sale | 2025-12-31 | 13G | PROCAP ACQUISITION CORP USD CL PCAP | J. Goldman & Co LP | 1,445,321 5.680% | -150,229 (-9.42%) | Filing History |
| 2026-02-17 09:00 am Sale | 2025-12-31 | 13G | 1RT ACQUISITION CORP. USD ONCH | J. Goldman & Co LP | 862,500 5.000% | -215,625 (-20.00%) | Filing History |
| 2025-11-14 3:08 pm Sale | 2025-09-30 | 13G | ZIMVIE INC ZIMV | J. Goldman & Co LP | 0 0.000% | -1,425,810 (Position Closed) | Filing History |
| 2025-11-14 3:02 pm Sale | 2025-09-30 | 13G | YORKVILLE ACQUISITION CORP UNI MCGAU | J. Goldman & Co LP | 0 0.000% | -800,000 (Position Closed) | Filing History |
| 2025-11-14 2:52 pm Sale | 2025-09-30 | 13G | GUARDIAN PHARMACY SVCS INC CL GRDN | J. Goldman & Co LP | 656,860 2.900% | -94,224 (-12.55%) | Filing History |
| 2025-11-14 2:45 pm Sale | 2025-09-30 | 13G | DMY SQUARED TECHNOLOGY GROUP I DMYY | J. Goldman & Co LP | 150,000 6.400% | -75,000 (-33.33%) | Filing History |
| 2025-11-14 2:36 pm Purchase | 2025-09-30 | 13G | PROCAP ACQUISITION CORP USD CL PCAP | J. Goldman & Co LP | 1,595,550 6.200% | 1,595,550 (New Position) | Filing History |
| 2025-11-14 2:28 pm Purchase | 2025-09-30 | 13G | 1RT ACQUISITION CORP. USD ONCH | J. Goldman & Co LP | 1,078,125 6.200% | 1,078,125 (New Position) | Filing History |
| 2025-08-14 8:15 pm Purchase | 2025-06-30 | 13G | YORKVILLE ACQUISITION CORP UNI MCGAU | J. Goldman & Co LP | 800,000 5.200% | 800,000 (New Position) | Filing History |
| 2025-08-14 8:08 pm Purchase | 2025-06-30 | 13G | EAGLE PHARMACEUTICALS INC EGRX | J. Goldman & Co LP | 667,108 5.100% | 667,108 (New Position) | Filing History |
| 2025-08-14 7:59 pm Purchase | 2025-06-30 | 13G | DMY SQUARED TECHNOLOGY GROUP I DMYY | J. Goldman & Co LP | 225,000 9.600% | 32,189 (+16.69%) | Filing History |
| 2025-05-15 1:59 pm Purchase | 2025-03-31 | 13G | DMY SQUARED TECHNOLOGY GROUP I DMYY | J. Goldman & Co LP | 192,811 8.200% | 192,811 (New Position) | Filing History |
| 2025-02-14 3:47 pm Purchase | 2024-12-31 | 13G | ZIMVIE INC ZIMV | J. Goldman & Co LP | 1,425,810 5.200% | 1,425,810 (New Position) | Filing History |
| 2024-11-14 12:14 pm Purchase | 2024-09-30 | 13G | GUARDIAN PHARMACY SVCS INC CL GRDN | J. Goldman & Co LP | 751,084 8.200% | 751,084 (New Position) | Filing History |
| 2024-11-14 12:03 pm Sale | 2023-12-31 | 13G | NET LEASE OFFICE PPTYS COM NLOP | J. Goldman & Co LP | 672,455 4.600% | -363,406 (-35.08%) | Filing History |